Bayshore Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis Emerging Markets Value ETF
AVES
|
+$1.6M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$1.29M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$1.05M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$907K |
| 5 |
Dimensional US Targeted Value ETF
DFAT
|
+$730K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$492K |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
+$19K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.99% |
| 2 | Consumer Discretionary | 0.58% |
| 3 | Healthcare | 0.57% |
| 4 | Consumer Staples | 0.27% |
| 5 | Communication Services | 0.23% |
Similar funds
Bayshore Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Bayshore Asset Management held 31 positions worth $155M, up 17% from $132M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Bayshore Asset Management deployed $8.16M of net new capital in Q4 2022, opening 2 new positions and adding to 17 existing holdings. Its largest new stake was Cano Health, Inc.: 1,144 shares worth $157K.
By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vanguard Real Estate ETF, an estimated $492K trimmed.
- Bayshore Asset Management's largest Q4 2022 buy was Cano Health, Inc.: 1,144 shares worth $157K.
- Bayshore Asset Management added most to Avantis Emerging Markets Value ETF in Q4 2022, an estimated $1.6M increase.
- Bayshore Asset Management's biggest Q4 2022 reduction was Vanguard Real Estate ETF, cutting an estimated $492K.
- Bayshore Asset Management's ten largest holdings make up 85% of its $155M portfolio in Q4 2022.
- Bayshore Asset Management opened 2 new positions and closed 0 in Q4 2022.
- Bayshore Asset Management's portfolio value rose 17% quarter-over-quarter to $155M.
Based on Bayshore Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.